Romanian Railways (CFR: Cãile Ferate Române) has placed the order with a consortium made up of Siemens, Thales and Nokia Siemens Networks. The deal is worth around 35 million Euros. Commissioning of the first ETCS Level 2 line in Romania is planned for 2014.
The 38 kilometer long link forms part of the Pan/ European rail traffic corridor IV, running from Germany through Slovakia, Hungary, Romania and Bulgaria to Turkey. Siemens will supply two Simis W electronic inter/ locking systems, the Vicos operations control system, the onboard units and 90 Eurobalises. The components will be manufactured in Braunschweig and Berlin.
By means of standardized interfaces between vehicle and track, the ETCS ensures interoperability across national borders. In this track section, vehicles equipped with ETCS technology work out their respective location themselves and transmit it cyclically to the RBC. From the connected interlocking towers the RBC receives the con/ stantly updated process image and grants the vehicle permission to proceed by means of radio data transfer. The information is shown on the driver's cab display. The digital system GSM/R (Global System for Mobile Commu/ nication/Railways) is used for transmission; Eurobalises serve as reference points for localization.
The Siemens Mobility and Logistics Division (with headquarters in Munich) is a solution provider for customers whose business model is based on the optimization of passenger and freight transportation. Mobility and Logistics comprises all Siemens businesses in the field of international traffic, transportation and logistics management. These include rail automation, infrastructure logistics, intelligent traffic and transportation systems and also technologies for the extension of the elec/ tromobility infrastructure.
Further information can be found on the Internet at http://www.siemens.com/mobility/logisticsEditor:
13.02.2017 | Event News
10.02.2017 | Event News
09.02.2017 | Event News
23.02.2017 | Physics and Astronomy
23.02.2017 | Earth Sciences
23.02.2017 | Life Sciences